- Home
- MSC vs PRAX Comparison
MSC vs PRAX Comparison
Compare MSC & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSC
- PRAX
- Stock Information
- Founded
- MSC 2000
- PRAX 2015
- Country
- MSC Hong Kong
- PRAX United States
- Employees
- MSC N/A
- PRAX N/A
- Industry
- MSC Hotels/Resorts
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- MSC Consumer Discretionary
- PRAX Health Care
- Exchange
- MSC Nasdaq
- PRAX Nasdaq
- Market Cap
- MSC 572.0M
- PRAX 599.7M
- IPO Year
- MSC 2018
- PRAX 2020
- Fundamental
- Price
- MSC $4.24
- PRAX $47.26
- Analyst Decision
- MSC
- PRAX Strong Buy
- Analyst Count
- MSC 0
- PRAX 10
- Target Price
- MSC N/A
- PRAX $99.20
- AVG Volume (30 Days)
- MSC 10.3K
- PRAX 297.8K
- Earning Date
- MSC 08-12-2025
- PRAX 08-12-2025
- Dividend Yield
- MSC N/A
- PRAX N/A
- EPS Growth
- MSC N/A
- PRAX N/A
- EPS
- MSC N/A
- PRAX N/A
- Revenue
- MSC $650,708,000.00
- PRAX $8,122,000.00
- Revenue This Year
- MSC $8.92
- PRAX N/A
- Revenue Next Year
- MSC N/A
- PRAX $6,358.50
- P/E Ratio
- MSC N/A
- PRAX N/A
- Revenue Growth
- MSC 19.57
- PRAX 270.02
- 52 Week Low
- MSC $2.30
- PRAX $26.70
- 52 Week High
- MSC $9.30
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- MSC 73.78
- PRAX 66.10
- Support Level
- MSC $3.05
- PRAX $40.93
- Resistance Level
- MSC $4.66
- PRAX $44.40
- Average True Range (ATR)
- MSC 0.37
- PRAX 2.24
- MACD
- MSC 0.18
- PRAX 0.11
- Stochastic Oscillator
- MSC 78.79
- PRAX 89.64
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.